Completed NA INTERVENTIONAL 3-arm NCT03588468

Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study

Expanding the Biomarkers in Familial Amyloid Neuropathy: Magnetic Resonance Imaging (MRI) and Motor Unit Estimation by Electrophysiological Study

Sponsor: Assistance Publique Hopitaux De Marseille

Conditions Amyloid Neuropathies Transthyretin Amyloidosis

Interventions Electrophysiological biomarkers MRI biomarkers

Updated 6 times since 2018 Last updated: Oct 2, 2022 Started: Sep 20, 2018 Primary completion: Dec 18, 2019 Completion: Dec 18, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Amyloid Neuropathies and Transthyretin Amyloidosis and is currently completed. Assistance Publique Hopitaux De Marseille leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2022 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Nov 2022 [monthly]

Unknown Status NA
Aug 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status

▶ Show 1 earlier version

Aug 2018 — Aug 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique Hopitaux De Marseille

Data source: Assistance Publique Hopitaux De Marseille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marseille, France